Evaluation of ferritin, interleukin-6, interleukin-8 and tumor necrosis factor alpha in the differentiation of exudates and transudates in pleural effusions

被引:0
作者
Alexandrakis, MG
Coulocheri, SA
Bouros, D
Eliopoulos, GD
机构
[1] Univ Hosp Heraklion, Dept Hematol, Heraklion, Crete, Greece
[2] Univ Hosp Heraklion, Dept Thorac Med, Heraklion, Crete, Greece
[3] Univ Athens, Sch Med, Dept Biol Chem, GR-10679 Athens, Greece
关键词
pleural effusion; ferritin; interleukin-6; interleukin-8; tumor necrosis factor-alpha; lung cancer;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In an attempt to define diagnostic criteria for the differentiation of pleural exudates from transudates, we measured ferritin (FER), interleukin-6 (IL-6), interleukin-8 (IL-8) and tumor necrosis factor-alpha (TNF-alpha) in pleural effusions and blood serum in 84 consecutive patients with pleural effusions of various etiologies. Concentrations of FER, IL-8 and TNF-alpha were significantly higher in serum and pleural effusion in patients with exudates than in patients with transudates. Serum concentrations of IL-6 were not significantly increased in pleural exudate patients (9.78 +/- 17.12 fmol/L) compared to transudate patients (4.05 +/- 2.33 fmol/L), while significant differences were found between pleural exudates and transudates (p<0.001). Increased levels of FER were found in serum and pleural effusion of cancer patients in comparison to non cancer patients (p<0.001 and p<0.001, respectively). Serum concentrations of IL-6, IL-8, and TNF-alpha were not significantly ina eased in cancel compared to non-cancel patients, while increased concentrations of IL-6 and IL-8 were found in pleural fluid of patients with cancer in comparison to non-cancer patients. Finally/ no statistically significant differences were found in serum and pleural TNF-alpha concentrations among patients with cancer and patients with non-cancer effusion. We conclude that FER, IL-6, IL-8 and TNF-alpha concentrations in pleural effusions are useful markers in differentiating exudates from transudates.
引用
收藏
页码:3607 / 3612
页数:6
相关论文
共 35 条
[1]  
ANTONY VB, 1993, J IMMUNOL, V151, P7216
[2]  
BETSHOLTZ C, 1989, INT J CANCER, V39, P502
[3]   COMPARATIVE-ANALYSIS OF THE BIOCHEMICAL PARAMETERS USED TO DISTINGUISH BETWEEN PLEURAL TRANSUDATES AND EXUDATES [J].
BURGESS, LJ ;
MARITZ, FJ ;
TALJAARD, JJF .
CHEST, 1995, 107 (06) :1604-1609
[4]  
DEKKER A, 1978, AM J CLIN PATHOL, V70, P855
[5]   CA-72-4 RADIOIMMUNOASSAY IN THE DIAGNOSIS OF MALIGNANT EFFUSIONS - COMPARISON OF VARIOUS TUMOR-MARKERS [J].
FERRONI, P ;
SZPAK, C ;
GREINER, JW ;
SIMPSON, JF ;
GUADAGNI, F ;
JOHNSTON, WW ;
COLCHER, D .
INTERNATIONAL JOURNAL OF CANCER, 1990, 46 (03) :445-451
[6]   MONONUCLEAR-CELLS IN EXUDATIVE MALIGNANT PLEURAL EFFUSIONS - CHARACTERIZATION OF PLEURAL PHAGOCYTIC-CELLS [J].
GJOMARKAJ, M ;
PACE, E ;
MELIS, M ;
SPATAFORA, M ;
TOEWS, GB .
CHEST, 1994, 106 (04) :1042-1049
[7]  
GOODMAN RB, 1992, J IMMUNOL, V148, P457
[8]  
HALL WJ, 1985, ANN INTERN MED, V103, P799
[9]  
HASDAY JD, 1990, J IMMUNOL, V145, P371
[10]   Diagnostic value of tests that discriminate between exudative and transudative pleural effusions [J].
Heffner, JE ;
Brown, LK ;
Barbieri, CA ;
Burgess, L ;
Cruz, E ;
Pose, A ;
Roth, BJ ;
Suay, VG ;
Valdes, L .
CHEST, 1997, 111 (04) :970-980